22:48:55 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



V:HEM - Hemostemix Inc. - http://www.hemostemix.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HEM - V  62.00.04·0.04516.00.045+0.00512.548.0260.04  0.045  0.040.175  0.0413:57:45Mar 2015 min RT 2¢
TSX-V - V62.00.04·0.04516.00.045+0.00512.532.0130.04  0.045  0.040.175  0.0413:57:4515 min
Alpha - A 0.045+0.00512.54.0010.045  0.045  0.04513:57:4515 min
CX2 - H 0.0412.0020.04  0.04  0.0409:31:3415 min

Recent Trades - All 6 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
13:57:45A0.0450.0054,0007 TD Sec1 AnonymousK
13:57:45V0.0450.0053,0007 TD Sec7 TD SecK
13:57:45V0.0450.0053,0007 TD Sec7 TD SecK
13:29:58V0.04 26,0001 Anonymous9 BMO NesbittKL
09:31:34H0.04 2,0001 Anonymous1 AnonymousK
09:31:34H0.04 10,0001 Anonymous1 AnonymousK
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-03-07 16:13C:HEM0.08News ReleaseHemostemix hires Oak Hill for advisory services
2024-02-06 14:15C:HEMNews ReleaseHemostemix releases clinical results via Biomedical
2024-01-03 20:06C:HEM0.07Private PlacementHemostemix 2,669,875-share private placement
2023-12-29 16:15C:HEM0.07News ReleaseHemostemix clarifies Oct. 3 PR on private placement
2023-12-15 17:44C:HEM0.07Private Placement - DebentureHemostemix debentures amended
2023-11-29 18:15C:HEM0.07SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-29 18:13C:HEM0.07SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-10-30 15:19C:HEM0.085News ReleaseHemostemix's ACP-01 study published in Stem Cell
2023-10-23 14:42C:HEM0.10News ReleaseHemostemix amends terms of $2.5-million debenture
2023-10-03 14:12C:HEM0.12News ReleaseHemostemix closes $320,125 private placement
2023-10-02 19:36C:HEM0.12Private PlacementHemostemix 3,362,833-unit private placement
2023-09-27 17:15C:HEM0.105News ReleaseHemostemix arranges $325,125 private placement
2023-09-12 17:06C:HEM0.115News ReleaseHemostemix submits NCP-01 study for peer review
2023-08-29 16:14C:HEM0.125News ReleaseHemostemix forms Hemostemix Quebec
2023-08-29 15:47C:HEM0.12SEDAR Interim MD & ASEDAR Interim MD & A
2023-08-29 15:44C:HEM0.12SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-14 12:00C:HEM0.145News ReleaseHemostemix wins arbitration against Burchardt
2023-08-08 15:14C:HEM0.14News ReleaseHemostemix submits cardiomyopathy study
2023-06-28 16:09C:HEM0.12News ReleaseHemostemix closes $403,539 tranche of private placement
2023-06-21 17:13C:HEM0.12News ReleaseHemostemix outlines use of proceeds from financing